
269 episodes

AUAUniversity American Urological Association
-
- Education
-
-
4.5 • 29 Ratings
-
The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
-
AUA2022 JU Lecture: Engaging Patients: A Challenge to our Care Delivery and Research Priorities
AUA2022 JU Lecture: Engaging Patients: A Challenge to our Care Delivery and Research Priorities
Speaker: Angela Smith, MD, MS
University of North Carolina at Chapel Hill -
AUA2022 Ramon Guiteras Lecture: How to Reach Excellence in Urology: Challenges and Opportunities
AUA2022 Ramon Guiteras Lecture: How to Reach Excellence in Urology: Challenges and Opportunities
Speaker: Francesco Montorsi, MD -
AUA2022 John Duckett Memorial Lecture: Lifelong Learning, What’s in it for me?
AUA2022 John Duckett Memorial Lecture: Lifelong Learning, What’s in it for me?
Speaker: David Joseph, MD
Professor of Urology / Vice Chair Academic Affairs / Beverly P. Head Chair in Pediatric Urology at Children's of Alabama
Children's of Alabama -
AUA2022 John K. Lattimer Lecture: Testosterone, Science and Human Dignity
AUA2022 John K. Lattimer Lecture: Testosterone, Science and Human Dignity
Speaker: Abraham Morgentaler, MD, FACS -
AUA2022 Presidential Address
AUA2022 Presidential Address
Speaker: Raju Thomas, MD, FACS, FRCS, MHA
Urology Chair, Tulane University Medical Center and AUA President
Tulane University -
PARP Inhibitors in Advanced Prostate Cancer Care
PARP Inhibitors in Advanced Prostate Cancer Care Podcast
CME Available: https://auau.auanet.org/node/37321
Host: Jay D. Raman, MD, FACS
Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
1. Identify approved PARP Inhibitors for prostate cancer and patients who may benefit from PARP Inhibitor‐based therapy.
2. Evaluate available clinical safety and efficacy data for PARP Inhibitors.
3. Describe indications and contraindications for PARP Inhibitors in patients with advanced prostate cancer.
4. Identify how to manage adverse events that patients may experience while taking a PARP Inhibitors.
ACKNOWLEDGEMENTS:
This series is supported by independent educational grants from:
Astellas
AstraZeneca
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lantheus Medical Imaging
Merck & Co., Inc.
Pfizer, Inc.
Sanofi Genzyme
Customer Reviews
Very good content, but please fix the audio component so that I can actually hear the podcast
Excellent series on GU malignancies at the end of 2020. Please please please fix the audio to make it legible.
Very good content, music is not nice
Please get rid of music in beginning and end. It’s difficult to hear the speakers over it. Also some audio quality is not good.
Content is excellent from world experts
Thank you
Perfect for my long drives to a satellite hospital.